Looking For Hot Stocks? - You Should Watch ( SYNM, GNOM, CPRX, WCN )

Los Angelas, CA -- (SBWIRE) -- 09/18/2012 -- Syntroleum Corpor (NCM:SYNM) reported EPS of -0.03. For the Current Fiscal year, the company is expected to report EPS of 0.10. For the Next Quarter and Next Year, the company is expected to report EPS of 0.03 and 0.24 respectively. At Current Market Price, SYNM is in distance of +18.43% from its 50-day Moving Average price of $0.7177 and +5.69% from its 200-day Moving Average price of $0.8042. Shares of Syntroleum (NASDAQ: SYNM [FREE Stock Trend Analysis]), the Tulsa, OK licensor of synthetic liquid hydrocarbon technology, rose 18.06% Monday on 4 times average volume.Syntroleum reported Monday that the EPA announced an increase to the renewable volume obligation (RVO) for biomass based diesel under RFS2 to 1.28 billion gallons in 2013 from 1.0 billion gallons in 2012.The renewable diesel produced by Syntroleum's affiliate Dynamic Fuels qualifies as biomass based diesel under the RVO. Renewable diesel is a direct drop-in replacement for petroleum diesel and meets the same ASTM D975 standards. The increased RVO provides the regulatory certainty needed to enable manufacturers of renewable fuels to continue to grow production.Syntroleum closed at $0.85 on Monday.

Should Investors Buy SYNM Now? Get Free Analysist Report

Complete Genomics (NGM:GNOM) is very active today and traded between $3.02 - 3.09 with total traded volume of 7468136 shares. At a current price of 3.02, GNOM is +0.35 - +13.11% from the previous close of $2.67. Moreover, At Current Market Price, GNOM is in distance of +13.78% from its 50-day Moving Average price of $2.6543 and +18.08% from its 200-day Moving Average price of $2.5575. Complete Genomics (Nasdaq: GNOM ) finished up 13% after agreeing to be purchased by Chinese gene-sequencing operator BGI-Shenzen for $3.15 per share. While today's pop may seem small, shares sit only $0.13 under the deal price, and it's important to remember that it's more than a 50% premium to when Complete Genomics announced it was looking for acquirers. Not that it's any consolation for long-term holders, as shares traded at about $15 as recently as last summer. The company remains wildly unprofitable, but its more accurate, albeit slower, technology gives BGI not only a U.S. presence but also leverage against Illumina, its main supplier. Although it will operate as a separate entity, it's still a disappointing end for the promising small sequencer.

Should Investors Buy GNOM Now? Get Free Analysist Report

Catalyst Pharmace (NCM:CPRX) is +0.16 - +11.51% from the previous close of $1.39. It traded between $1.4501 - 1.56 with total traded volume of 2229709 shares. Keep a close eye on CPRX, as the stock has been showing unusual moves over the past weeks. At Current market price, CPRX has recovered +210.00% from its 52-week Low of 0.50 and has Pulled back -21.32% from its 52-week high of 1.97. The shares of the company fell 13% in the last one year. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.

Should Investors Buy CPRX Now? Get Free Analysist Report

Waste Connections (NYSE:WCN) is +3.14 - +10.58% from the previous close of $29.67. It traded between $29.89 - 32.98 with total traded volume of 3404401 shares. Keep a close eye on WCN, as the stock has been showing unusual moves over the past weeks. At Current market price, WCN has recovered +14.32% from its 52-week Low of 28.70 and has Pulled back -8.73% from its 52-week high of 35.95. Waste Connections Inc. (WCN): Waste Management Services companies have been facing some challenges as the weak economy has hurt MSW volumes. However, shares of WCN popped up recently. This was after the company announced that it is acquiring R360 Environmental Solutions Inc., a leading provider of non-hazardous oilfield waste treatment, recovery and disposal services. WCN is acquiring R360 for approximately $1.3 billion in cash. The acquisition will allow WCN to expand its E&P disposal activities. The acquisition also adds a new revenue stream for WCN. It makes a lot of sense from a strategic point of view and hence the sharp rise in WCN shares.

Should Investors Buy WCN Now? Get Free Analysist Report

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com